These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 20512194)
21. Diagnostic value of PET/CT for predicting of neoadjuvant chemotherapy response. Seemann MD Eur J Med Res; 2007 Feb; 12(2):90-1. PubMed ID: 17369123 [No Abstract] [Full Text] [Related]
22. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Kut V; Spies W; Spies S; Gooding W; Argiris A Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894 [TBL] [Abstract][Full Text] [Related]
23. Bilateral ovarian metastases from breast carcinoma on FDG PET-CT. Ho L; Quan V; Henderson R Clin Nucl Med; 2007 Dec; 32(12):935-6. PubMed ID: 18030045 [TBL] [Abstract][Full Text] [Related]
24. [Bone scintigraphy in the control of bone metastasis of breast cancer during pamidronate and tamoxifen combination therapy]. Massoudi S; Brenner W; Czech N; Kampen WU; Henze E Nuklearmedizin; 2001 Apr; 40(2):N10-2. PubMed ID: 11354989 [No Abstract] [Full Text] [Related]
25. Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers. Katayama T; Kubota K; Machida Y; Toriihara A; Shibuya H Ann Nucl Med; 2012 Jun; 26(5):426-35. PubMed ID: 22477261 [TBL] [Abstract][Full Text] [Related]
26. Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. Beresford M; Lyburn I; Sanghera B; Makris A; Wong WL Breast J; 2007; 13(4):424-5. PubMed ID: 17593051 [No Abstract] [Full Text] [Related]
27. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT. Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806 [TBL] [Abstract][Full Text] [Related]
28. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259 [TBL] [Abstract][Full Text] [Related]
29. PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors? Pfannenberg C; Aschoff P; Dittmann H; Mayer F; Reischl G; von Weyhern C; Kanz L; Claussen CD; Bares R; Hartmann JT J Nucl Med; 2010 Jun; 51(6):845-53. PubMed ID: 20484416 [TBL] [Abstract][Full Text] [Related]
30. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Tateishi U; Gamez C; Dawood S; Yeung HW; Cristofanilli M; Macapinlac HA Radiology; 2008 Apr; 247(1):189-96. PubMed ID: 18372468 [TBL] [Abstract][Full Text] [Related]
31. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging. Taira N; Ohsumi S; Takabatake D; Hara F; Takashima S; Aogi K; Takashima S; Inoue T; Sugata S; Nishimura R Jpn J Clin Oncol; 2009 Jan; 39(1):16-21. PubMed ID: 18997183 [TBL] [Abstract][Full Text] [Related]
32. [Clinical efficacy of bone scintigraphy for metastatic bone tumors]. Nakajima T; Sugiyama S; Yamakawa M Rinsho Hoshasen; 1983 May; 28(5):579-83. PubMed ID: 6887613 [No Abstract] [Full Text] [Related]
33. FDG PET and SPECT of bone metastases in breast cancer. Williams HT; Smith S AJR Am J Roentgenol; 2005 Dec; 185(6):1651-2; author reply 1652-3. PubMed ID: 16304028 [No Abstract] [Full Text] [Related]
34. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging. Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223 [TBL] [Abstract][Full Text] [Related]
35. "Role of bone scintigraphy in the management of patients with carcinoma of breast". Krishna BA Indian J Cancer; 1982 Mar; 19(1):47-51. PubMed ID: 7106833 [No Abstract] [Full Text] [Related]
36. A woman with primary breast cancer and a solitary sternal metastasis. Menter A; Urquhart A; Borges V; Rabinovitch R; Singh M; Robinson W; Seligman P; Finlayson C; Elias A Oncology (Williston Park); 2006 Aug; 20(9):1068-71, 1075, 1079-80. PubMed ID: 16986350 [No Abstract] [Full Text] [Related]
37. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer]. Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373 [TBL] [Abstract][Full Text] [Related]
38. [Bone scintigram of breast cancer patients and its indications]. Shichijo Y; Inoue Y; Ibukuro K; Nishi T; Hirose T Rinsho Hoshasen; 1986 Mar; 31(3):359-62. PubMed ID: 3723827 [No Abstract] [Full Text] [Related]
39. The role of computed tomography in the detection of bone metastases in breast cancer patients. Muindi J; Coombes RC; Golding S; Powles TJ; Khan O; Husband J Br J Radiol; 1983 Apr; 56(664):233-6. PubMed ID: 6831145 [TBL] [Abstract][Full Text] [Related]
40. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer. Buscombe JR; Holloway B; Roche N; Bombardieri E Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]